Pansong Li

886 citations
29 papers · 340 indexed · h-index 12
Topics
Cancer Genomics and Diagnostics (14 papers)Lung Cancer Treatments and Mutations (8 papers)Lung Cancer Research Studies (7 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaOncogene
Partner nations
ChinaUnited StatesItaly

In The Last Decade

Pansong Li

27 papers receiving 339 citations

Peers

Pansong Li
Comparison fields: 5 of 46
  • Oncology 178
  • Pulmonary and Respiratory Medicine 161
  • Molecular Biology 106
  • Cancer Research 98
  • Plant Science 45
Replace Philip Jermann with:
Philip Jermann Switzerland
Anne‐Katrin Zimmermann Switzerland
Suenori Chiku Japan
Xinkai Cao China
Víctor Rodríguez-Freixinós Spain
Adrien Briaux France
Ya-Nong Wang China
Hualei Bu China
Thomas P. Howard United States
Maria Mosor Poland
Pansong Li relative to Philip Jermann Switzerland Philip Jermann's profile →
Citations per field
00.5×2.6×
Philip Jermann · 1×
Citations per year

Countries citing papers authored by Pansong Li

Since Specialization
Citations

This map shows the geographic impact of Pansong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pansong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pansong Li more than expected).

Fields of papers citing papers by Pansong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pansong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pansong Li. The network helps show where Pansong Li may publish in the future.

Co-authorship network of co-authors of Pansong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Pansong Li. A scholar is included among the top collaborators of Pansong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pansong Li. Pansong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 3
4 2
5 0
6 2
7 12
8 5
9 28
10 17
11 16
12 42
13 19
14 31
15 18
16 14
17 1
18 2
19 1
20 38

About Pansong Li

Pansong Li is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 340 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (14 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Research Studies (7 papers). The work is most often cited by research in Oncology (178 citations), Cancer Research (98 citations) and Pulmonary and Respiratory Medicine (161 citations). Pansong Li has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Yanfang Guan, Li Li, Xuefeng Xia, Lianpeng Chang, Wenhao Zhou, Wenhua Fan, Liancheng Li, Gaisheng Zhang, Zhao‐Shi Xu and Dagui Lin. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026